GlaxoSmithKline Consumer Healthcare has locked in upper circuit of 20% at Rs 3,652 on the BSE, also its record high after its parent company GlaxoSmithKline Plc made an open offer to acquire additional 31.84% stake in the company at price of Rs 3,900 per share.
GlaxoSmithKline Plc plans to raise its stake in its Indian consumer products arm to 75% from 43.16% via an open offer.
“GlaxoSmithKline Pte Ltd along with Horlicks Limited and GlaxoSmithKline plc in their capacity as persons acting in concert propose to acquire 13.38 million equity shares of Rs 10 each representing 31.84% of the total voting share capital of the GlaxoSmithKline Consumer Healthcare at Rs 3,900 per equity share,” HSBC Securities, the manager of the open offer said in a statement on behalf of the company.
A combined around 5,000 shares have changed hands on the counter in opening deals. There are pending buy orders for 260,563 shares on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
